Tech Company Financing Transactions

Neurana Pharmaceuticals Funding Round

Sofinnova Ventures, H.I.G. Capital and Longitude Capital Management joined a $60 million Series A capital raise for Neurana Pharmaceuticals. The financing round closed on 5/8/2018.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

4370 La Jolla Village Dr. 860
San Diego, CA 92122
USA

Phone

Undisclosed

Website

www.neuranapharma.com

Email Address

[email protected]

Overview

Neurana Pharmaceuticals is a privately held clinical stage San Diego based specialty pharmaceutical company developing a novel treatment for acute muscle spasms. The Company was founded in 2013 by veteran biotech entrepreneurs David F. Hale and Jeffrey Raser to focus on central nervous system (CNS) diseases and disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Craig Thompson

        

Chief Financial Officer

Kathy Scott

        

Chief Medical Officer

Randall Kaye

        

Browse more venture capital transactions:

Prev: 5/8/2018: BlueWillow Biologics venture capital transaction
Next: 5/8/2018: DAOstack venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary